Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Quince Therapeutics (QNCX)
NASDAQ:QNCX
Holding QNCX?
Track your performance easily
Quince Therapeutics (QNCX) Ownership Overview
18.39% Insiders
3.73% Mutual Funds
0.12% Other Institutional Investors
2.96% ETFs
74.79% Public Companies and
Individual Investors
The ownership structure of Quince Therapeutics (QNCX) stock is a mix of institutional, retail, and individual investors. Approximately 6.81% of the company’s stock is owned by Institutional Investors, 18.39% is owned by Insiders, and 74.79% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 03, 2024 | Dirk Thye Ceo And Chief Medical Officer,director | xxxxxxxxxxxxx | $107375 |
| Aug 22, 2024 | Charles S. Ryan President | xxxxxxxxxxxxx | $31452 |
| Aug 21, 2024 | Brendan Hannah Chief Business Officer And Coo | xxxxxxxxxxxxx | $24166 |
| Dec 14, 2023 | David Lamond Director | xxxxxxxxxxxxx | $69233 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,686,387 | Insider | 15.45% | 9,360,942 | |
| 1,193,486 | Institution | 2.76% | 1,670,880 | |
| 1,193,486 | Institution | 2.76% | 1,670,880 | |
| 843,941 | Insider | 1.95% | 1,181,517 | |
| 296,540 | Insider | 0.69% | 415,156 | |
| 253,989 | Institution | 0.59% | 355,585 | |
| 138,495 | Institution | 0.32% | 193,893 | |
| 122,461 | Insider | 0.28% | 171,445 | |
| 86,317 | Institution | 0.20% | 120,844 | |
| 14,974 | Institution | 0.03% | 20,964 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,193,486 | Institution | 2.76% | 1,670,880 | |
| 253,989 | Institution | 0.59% | 355,585 | |
| 138,495 | Institution | 0.32% | 193,893 | |
| 14,974 | Institution | 0.03% | 20,964 | |
| 11,013 | Institution | 0.03% | 15,418 | |
| 3,075 | Institution | <0.01% | 4,305 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 847,959 | Institution | 1.96% | 658,186 | |
| 345,527 | Institution | 0.80% | 268,198 | |
| 86,317 | Institution | 0.20% | 132,065 |
FAQ
Who Owns Quince Therapeutics (QNCX)?
According to the latest TipRanks data, approximately 0.12% of the company's stock is held by institutional investors, 18.39% is held by insiders, and 74.79% is held by retail investors.
What percentage of Quince Therapeutics (QNCX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.12% of Quince Therapeutics (QNCX) stock is held by institutional investors.
What percentage of Quince Therapeutics (QNCX) stock is held by retail investors?
According to the latest TipRanks data, approximately 74.79% of Quince Therapeutics (QNCX) stock is held by retail investors.
Who owns the most shares of Quince Therapeutics (QNCX)?
David Lamond owns the most shares of Quince Therapeutics (QNCX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.